Orexo announces NDA submission to FDA for opioid overdose therapy
Orexo has submitted a new drug application (NDA) to the US FDA for its high-dose rescue medication, OX124, for opioid overdose
Orexo has submitted a new drug application (NDA) to the US FDA for its high-dose rescue medication, OX124, for opioid overdose
What's Your Reaction?
